Select Publications
Book Chapters
1995, 'Neurotransmitter changes in Alzheimer's disease', in Tracey DJ; Paxinos G; Stone J (ed.), Neurotransmitters in the human brain: Conference in Honour of Istvan Tork, Plenum Press, New York, pp. 199 - 219
,1995, 'Serotonin and tachykinin systems', in The Rat Nervous System, Academic Press, Sydney, pp. 929 - 974
,1993, 'Neuropathological Correlates of Population-Based Studies of Neurodegenerative Diseases', in Beregi E; Gergely IA; Rajczi K (ed.), Recent Advances in Aging Science, Monduzzi, pp. 667 - 671
,1991, 'Serotonergic neurons in Parkinson’s disease using antibody PH8 to phenylalanine hydroxylase', in Blau N; Curtius HC; Levine RA; Cotton RGH (ed.), Pteridines and related biogenic amines, Walter de Gruyter & Co., Berlin, pp. 283 - 290
,1990, 'Catecholaminergic Neurons', in The Human Nervous System, Elsevier, pp. 1023 - 1049, http://dx.doi.org/10.1016/b978-0-12-547625-6.50036-2
,1990, 'Human Catecholaminergic Neurons', in Paxinos G (ed.), The Human Nervous System, Academic Press, San Diego, pp. 1023 - 1050
,1990, 'Human Homologs to Brainstem Nuclei Identified in Other Animals as Revealed by Acetylcholinesterase Activity', in The Human Nervous System, Elsevier, pp. 149 - 202, http://dx.doi.org/10.1016/b978-0-12-547625-6.50012-x
,1990, 'Progress in catecholamine research. Part B: Central aspects. Neurology and Neurobiology', in Paxinos G (ed.), The Human Nervous System, Academic Press, San Diego, pp. 149 - 202
,1989, 'Modulation of sensorimotor activity during alterations in behavioural states', in Sandler M; Dahlstrom A (ed.), Progress in Catecholamine Research Central Aspects, Alan R. Liss, New York, pp. 179 - 185
,1984, 'The organization and connections of the mesencephalic ventromedial tegmentum', in Bandler R (ed.), Modulation of sensorimotor activity during alterations in behavioral states proceedings of a satellite symposium of the XXIX Congress of the International Union of Physiological Sciences on modulation of sensorimotor activity during altered behavioral states, held at Cedar Lake, Queensland, Australia, September 4-8, 1983, Alan R. Liss, New York, pp. 39 - 73
,Journal articles
2024, 'A potential patient stratification biomarker for Parkinson´s disease based on LRRK2 kinase-mediated centrosomal alterations in peripheral blood-derived cells', npj Parkinson's Disease, 10, http://dx.doi.org/10.1038/s41531-023-00624-8
,2024, 'A protective role of ABCA5 in response to elevated sphingomyelin levels in Parkinson’s disease', npj Parkinson's Disease, 10, http://dx.doi.org/10.1038/s41531-024-00632-2
,2024, 'Letter to the editor on: Hornerin deposits in neuronal intranuclear inclusion disease: direct identification of proteins with compositionally biased regions in inclusions by Park et al. (2022)', Acta Neuropathologica Communications, 12, http://dx.doi.org/10.1186/s40478-023-01706-7
,2024, 'An attentional and working memory theory of hallucination vulnerability in frontotemporal dementia', Brain Communications, http://dx.doi.org/10.1093/braincomms/fcae123
,2024, 'ATP-binding cassette transporters as possible targets for the intervention of neurodegenerative diseases', Neural Regeneration Research, 19, pp. 721 - 722, http://dx.doi.org/10.4103/1673-5374.382239
,2024, 'Transitioning from Subtyping to Precision Medicine in Parkinson's Disease: A Purpose-Driven Approach', Movement Disorders, 39, pp. 462 - 471, http://dx.doi.org/10.1002/mds.29708
,2024, 'Rationale and Design of the “DIagnostic and Prognostic Precision Algorithm for behavioral variant Frontotemporal Dementia” (DIPPA-FTD) Study: A Study Aiming to Distinguish Early Stage Sporadic FTD from Late-Onset Primary Psychiatric Disorders', Journal of Alzheimer's Disease, 97, pp. 963 - 973, http://dx.doi.org/10.3233/JAD-230829
,2024, 'Predicting neurodegeneration from sleep related biofluid changes', Neurobiology of Disease, 190, http://dx.doi.org/10.1016/j.nbd.2023.106369
,2023, 'Author Correction: Defining early changes in Alzheimer’s disease from RNA sequencing of brain regions differentially affected by pathology (Scientific Reports, (2021), 11, 1, (4865), 10.1038/s41598-021-83872-z)', Scientific Reports, 13, http://dx.doi.org/10.1038/s41598-023-36807-9
,2023, 'Disrupted myelin lipid metabolism differentiates frontotemporal dementia caused by GRN and C9orf72 gene mutations', Acta Neuropathologica Communications, 11, http://dx.doi.org/10.1186/s40478-023-01544-7
,2023, 'Elevated GRO-α and IL-18 in serum and brain implicate the NLRP3 inflammasome in frontotemporal dementia', Scientific Reports, 13, http://dx.doi.org/10.1038/s41598-023-35945-4
,2023, 'Evaluation of plasma levels of NFL, GFAP, UCHL1 and tau as Parkinson's disease biomarkers using multiplexed single molecule counting', Scientific Reports, 13, http://dx.doi.org/10.1038/s41598-023-32480-0
,2023, 'Generation of the iPSC line FINi002-A from a male Parkinson's disease patient carrying compound heterozygous mutations in the PRKN gene', Stem Cell Research, 73, http://dx.doi.org/10.1016/j.scr.2023.103211
,2023, 'Heterogeneity of cortical pTDP-43 inclusion morphologies in amyotrophic lateral sclerosis', Acta Neuropathologica Communications, 11, http://dx.doi.org/10.1186/s40478-023-01670-2
,2023, 'Single-cell DNA methylation sequencing by combinatorial indexing and enzymatic DNA methylation conversion', Cell and Bioscience, 13, http://dx.doi.org/10.1186/s13578-022-00938-9
,2023, 'The importance of patient-centred drug development for amyotrophic lateral sclerosis', Neuropathology and Applied Neurobiology, 49, http://dx.doi.org/10.1111/nan.12944
,2023, 'Effects of STN/SNr deep brain stimulation in a case of progressive supranuclear palsy with a Parkinson disease phenotype', Journal of Neuropathology and Experimental Neurology, 82, pp. 821 - 823, http://dx.doi.org/10.1093/jnen/nlad052
,2023, 'Survival in sporadic ALS is associated with lower p62 burden in the spinal cord', Journal of Neuropathology and Experimental Neurology, 82, pp. 769 - 773, http://dx.doi.org/10.1093/jnen/nlad051
,2023, 'A blood-based marker of mitochondrial DNA damage in Parkinson's disease', Science Translational Medicine, 15, http://dx.doi.org/10.1126/SCITRANSLMED.ABO1557
,2023, 'Past antihypertensive medication use is associated with lower levels of small vessel disease and lower Aβ plaque stage in the brains of older individuals', Neuropathology and Applied Neurobiology, 49, pp. e12922, http://dx.doi.org/10.1111/nan.12922
,2023, 'Treatment with the copper compound CuATSM has no significant effect on motor neuronal pathology in patients with ALS', Neuropathology and Applied Neurobiology, 49, http://dx.doi.org/10.1111/nan.12919
,2023, 'Short tandem repeat expansions in sporadic amyotrophic lateral sclerosis and frontotemporal dementia', Science Advances, 9, http://dx.doi.org/10.1126/sciadv.ade2044
,2023, 'Prioritization of Drug Targets for Neurodegenerative Diseases by Integrating Genetic and Proteomic Data From Brain and Blood', Biological Psychiatry, 93, pp. 770 - 779, http://dx.doi.org/10.1016/j.biopsych.2022.11.002
,2023, 'Distribution Patterns of Astrocyte Populations in the Human Cortex', Neurochemical Research, 48, pp. 1222 - 1232, http://dx.doi.org/10.1007/s11064-022-03700-2
,2023, 'Riluzole is associated with decreasing neuritic plaque severity in amyotrophic lateral sclerosis', Brain, 146, pp. E17 - E19, http://dx.doi.org/10.1093/brain/awac467
,2023, 'Role of Oligodendrocyte Lineage Cells in Multiple System Atrophy', Cells, 12, http://dx.doi.org/10.3390/cells12050739
,2023, 'LATE-NC staging in routine neuropathologic diagnosis: an update', Acta Neuropathologica, 145, pp. 159 - 173, http://dx.doi.org/10.1007/s00401-022-02524-2
,2023, 'Correction to: Adaptive structural changes in the motor cortex and white matter in Parkinson’s disease (Acta Neuropathologica, (2022), 144, 5, (861-879), 10.1007/s00401-022-02488-3)', Acta Neuropathologica, 145, pp. 157, http://dx.doi.org/10.1007/s00401-022-02523-3
,2023, 'Distinct hypothalamic involvement in the amyotrophic lateral sclerosis-frontotemporal dementia spectrum', NeuroImage: Clinical, 37, http://dx.doi.org/10.1016/j.nicl.2022.103281
,2023, 'Live cell in situ lysosomal GCase activity correlates to alpha-synuclein levels in human differentiated neurons with LRRK2 and GBA1 mutations', Frontiers in Cellular Neuroscience, 17, http://dx.doi.org/10.3389/fncel.2023.1229213
,2023, 'Multiple pathways of lipid dysregulation in amyotrophic lateral sclerosis', Brain Communications, 5, http://dx.doi.org/10.1093/braincomms/fcac340
,2023, 'Poly-GA immunohistochemistry is a reliable tool for detecting C9orf72 hexanucleotide repeat expansions', Brain Pathology, http://dx.doi.org/10.1111/bpa.13216
,2023, 'Assessing utility of imaging based biomarker to differentiate pathologically classified frontotemporal lobar degeneration syndromes', Alzheimer's & Dementia, 19, http://dx.doi.org/10.1002/alz.075559
,2023, 'The relationship between traumatic brain injury and the neuropathology of dementia', Alzheimer's & Dementia, 19, http://dx.doi.org/10.1002/alz.061668
,2023, 'Visual rating scales of atrophy to differentiate Frontotemporal dementia from Primary psychiatric disorder: results from DIPPA study', Alzheimer's & Dementia, 19, http://dx.doi.org/10.1002/alz.073286
,2023, 'Visual rating scales of atrophy to differentiate Frontotemporal dementia from Primary psychiatric disorder: results from DIPPA study', Alzheimer's & Dementia, 19, http://dx.doi.org/10.1002/alz.081607
,2022, 'Dynamic network impairments underlie cognitive fluctuations in Lewy body dementia', npj Parkinson's Disease, 8, http://dx.doi.org/10.1038/s41531-022-00279-x
,2022, 'Effect of LRRK2 protein and activity on stimulated cytokines in human monocytes and macrophages', npj Parkinson's Disease, 8, http://dx.doi.org/10.1038/s41531-022-00297-9
,2022, 'Exploring the Sensitivity of Prodromal Dementia with Lewy Bodies Research Criteria', Brain Sciences, 12, http://dx.doi.org/10.3390/brainsci12121594
,2022, 'Identifying gene expression profiles associated with neurogenesis and inflammation in the human subependymal zone from development through aging', Scientific Reports, 12, http://dx.doi.org/10.1038/s41598-021-03976-4
,